Australian general practitioners are a step closer to safer prescribing standards after researchers identified 23 quality prescribing indicators (QPIs) for common conditions in primary care, according to a Monash University study published in the BMJ Quality & Safety. The framework addresses seven major therapeutic areas—proton pump inhibitors, vaccinations, blood pressure medications, anti-inflammatories, asthma inhalers, mental health treatments, and pain relief—to guide appropriate medicine initiation, ongoing monitoring, avoidance of high-risk combinations, and deprescribing, aiming to reduce medication-related harms and preventable hospital admissions.
Why Australia Needs New Primary Care Prescribing Indicators
While prescribing indicators are common in many health systems, Australian primary care has lacked an updated, nationally recognized set since 2006, leaving previous tools outdated and restricted to older patients. According to the research, medication-related problems impose a substantial cost burden on hospitals via preventable admissions. The new framework provides health professionals with a validated set of standards to evaluate and improve medicine use across general practice settings, reflecting evolving prescribing risks and contemporary clinical priorities, as noted by study authors.
Expert Insights on Clinical Integration and Safety
The 23 QPIs were developed by a Monash University team comprising two prominent GPs and three pharmacists through a rigorous review and consensus process. Professor Dimity Pond, Chair of RACGP Expert Committee – Research and a paper author, stated that the indicators target prescribing practices that may not align with best practice. She noted that the framework is designed to draw attention to specific high-risk instances and integrate smoothly into routine quality improvement activities without imposing an undue administrative burden on clinicians.
Associate Professor Johnson George, senior author from Monash University’s Centre for Medicine Use and Safety, described the framework as a critical step forward for patient safety. He stated that the indicators offer a practical method for all health professionals to identify potentially inappropriate prescribing, monitor practices, and support improvements in safe medicine use, having been endorsed by an expert panel of general practitioners, nurse practitioners, pharmacists, and professional bodies.
Pro Tip: Integrating QPIs into Practice
Researchers suggest that these indicators can become part of routine clinic-level practice through audit and feedback mechanisms, allowing periodic analysis of prescribing data to highlight strengths and identify Continuing Professional Development (CPD) opportunities.
The next phase of the research involves a randomized controlled trial testing the indicators in primary care clinics. This trial forms part of the broader $4 million MRFF APRICOT project, which will incorporate educational audits, feedback strategies, and other tools to support and enhance medication safety across Australian general practices.
Frequently Asked Questions
What are quality prescribing indicators (QPIs)?
They are evidence-based tools designed to guide appropriate medicine initiation, ongoing monitoring, avoidance of high-risk prescribing combinations, and deprescribing for common conditions.
Which therapeutic areas do the new QPIs cover?
The 23 indicators cover proton pump inhibitors, vaccinations, blood pressure medications, anti-inflammatories, asthma inhalers, mental health treatments, and pain relief.
Who developed the new prescribing indicators?
A team at Monash University, including general practitioners and pharmacists, developed the framework through a rigorous review and consensus process published in the BMJ Quality & Safety.
Join the conversation: Share your thoughts on implementing new prescribing indicators in your practice by leaving a comment below, or subscribe to our newsletter for the latest updates on primary care research.